1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Diabetic Ulcers Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Diabetic Ulcers Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • January 2019
  • 382 pages
  • ID: 5731100
  • Format: PDF
  • By Transparency Market Research

Summary

Table of Contents

Global Diabetic Ulcers Treatment Market: Overview
This report analyzes the current and future scenario of the global diabetic ulcers treatment market. Rise in the prevalence of diabetic foot ulcers, surge in adoption of technologically advanced wound care products, increase in geriatric population, and rise in patient awareness and health care expenditure are key factors that are projected to drive the global market during the forecast period.

The global diabetic ulcers treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market.It also provides information and data analysis of the global market with respect to the segments based on ulcer type, treatment type, grade, end-user, and region.

A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section.Additionally, the section comprises a competitive matrix and company profiles along with business overview to understand the competitive landscape in the market.

This section of the report also provides market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global diabetic ulcers treatment market.

Global Diabetic Ulcers Treatment Market: Key Segments
The global diabetic ulcers treatment market has been segmented based on ulcer type, treatment type, grade, end-user, and region.In terms of ulcer type, the global market has been classified into foot ulcer, mouth ulcer, skin ulcer, corneal ulcer, and others.

The foot ulcer segment has been further sub-segmented into neuropathic ulcer and ischemic ulcer and neuro-ischemic ulcer.Based on treatment type, the diabetic ulcers treatment market has been categorized into wound care dressings, wound care devices, active therapies, and others.

The wound care dressings segment has been further sub-segmented into antimicrobial dressings, foam dressings, film dressings, alginate dressings, hydrogel dressings, and others.The wound care devices segment has been further split into negative pressure wound therapy, ultrasound therapy, and HBOT and electromagnetic therapy.

The active therapies segment has been further sub-segmented into skin grafts and substitutes, growth factors, and hemostatic agents and sealants. The others segment has been further bifurcated into pressure relief devices, traditional wound care products, and others. Based on grade, the market has been classified into grade 1, grade 2, grade 3, grade 4, and grade 5. In terms of end-user, the market has been split into hospital inpatient settings, hospital outpatient settings, community health centers, and home health care. Based on region, the global market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these segments have been provided for the period from 2017 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Diabetic Ulcers Treatment Market: Regional Outlook
In terms of region, the global diabetic ulcers treatment market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, Russia and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, Israel, and rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2017 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report
The report also profiles major players in the global diabetic ulcers treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Smith & Nephew plc, Integra Life Sciences Corporation, Hill-Rom Holdings, Inc., MölnlyckeHealth Care AB, Essity Aktiebolag, Cardinal Health, 3M Healthcare, B. Braun Melsungen AG, AcelityL.P., Inc., and ConvaTec, Inc.

The global diabetic ulcers treatment market has been segmented as below:

Global Diabetic Ulcers Treatment Market, by Ulcer Type
Foot Ulcer
Neuropathic Ulcer
Ischemic Ulcers and Neuro-Ischemic Ulcer
Mouth Ulcer
Skin Ulcer
Corneal Ulcer
Others

Global Diabetic Ulcers Treatment Market, by Treatment Type
Wound Care Dressings
Antimicrobial Dressings
Foam Dressings
Film Dressings
Alginate Dressings
Hydrogel Dressings
Other Dressings
Wound Care Devices
Negative Pressure Wound Therapy (NPWT)
Ultrasound Therapy
HBOT and Electromagnetic Therapy
Active Therapies
Skin Grafts & Substitutes
Growth Factors
Hemostatic Agents and Sealants
Others

Pressure Relief Devices
Traditional Wound Care Products
Others

Global Diabetic Ulcers Treatment Market, by Grade
Grade 1
Grade 2
Grade 3
Grade 4
Grade 5

Global Diabetic Ulcers Treatment Market, by End-user
Hospital Inpatient Settings
Hospital Outpatient Settings
Community Health Centers
Home Health Care

Global Diabetic Ulcers Treatment Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($5795)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Leber’s Hereditary Optic Neuropathy (Leber optic atrophy) - Pipeline Review, H2 2019

Leber’s Hereditary Optic Neuropathy (Leber optic atrophy) - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Leber’s Hereditary Optic Neuropathy (Leber optic atrophy) - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Leber’s Hereditary Optic Neuropathy (Lebe ...

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2020

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2020

  • $ 2000
  • January 2020

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2020SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline ...

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline Review, H1 2020

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline Review, H1 2020

  • $ 2000
  • January 2020

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline Review, H1 2020SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Primary Biliary Cholangitis - Pipeline Review, H1 ...


ref:plp2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on